AccuLine vs MeMed
AccuLine vs MeMed, compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: AccuLine is on 55/100 and MeMed on 61/100.
Where each one leads
AccuLine
- agent readiness: 50/100 against 35/100
- headcount growth: +19.0% against -8.4%
MeMed
- our overall score: 61/100 against 55/100
- domain rating: 46/100 against 26/100
- headcount: 99 against 11
- funding raised: $196M against $5.5M
- LinkedIn following: 21,207 against 3,578
At a glance
| Measure | AccuLine | MeMed |
|---|---|---|
| What it is | Developing CORA, a smart exam for early detection of coronary artery disease. | MeMed develops and commercializes host immune response diagnostic solutions to address complex clinical dilemmas and improve patient outcomes. |
| Category | Healthcare, Biomarkers, Heart, Coronary Artery Disease | Healthcare, Blood, Diagnostics, MedTech |
| Sells toBusiness model | B2B | B2B, B2G |
| Offering | Software | Software, Hardware |
| Founded | 2022 | 2009 |
| Headquarters | Not published | Tirat Carmel, Israel |
| Status | Inactive | Active |
Size, funding and growth
| Measure | AccuLine | MeMed |
|---|---|---|
| Employees | 11 | 99 |
| Headcount growthLast 12 months | +19.0% | -8.4% |
| Total funding | $5.5M | $196M |
| Latest round | Seed | Series E |
| LinkedIn followers | 3,578 | 21,207 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | AccuLine | MeMed |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 55/100 | 61/100 |
| Traction | 44/100 | 60/100 |
| Team | 70/100 | 70/100 |
| Search visibility | 33/100 | 29/100 |
| Quality | 58/100 | 65/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (50/100) | F (35/100) |
| Domain ratingLink authority, 0-100 | 26/100 | 46/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | AccuLine | MeMed |
|---|---|---|
| Hosting | Google Cloud | Self Managed |
| CMS | Not detected | WordPress |
| Frameworks | Not detected | Jquery |
| Analytics | Not detected | Google Analytics 4, Google Tag Manager |
AccuLine vs MeMed: common questions
Which is better, AccuLine or MeMed?
On our 0-100 score MeMed rates higher (61/100 against 55/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.
How do AccuLine and MeMed compare on the numbers?
AccuLine leads on agent readiness (50/100 against 35/100), headcount growth (+19.0% against -8.4%). MeMed leads on our overall score (61/100 against 55/100), domain rating (46/100 against 26/100), headcount (99 against 11), funding raised ($196M against $5.5M), LinkedIn following (21,207 against 3,578).
Read the full AccuLine review and pricing or the MeMed review and pricing. You can also browse other AccuLine alternatives we track.